First book that covers key pharmacovigilance issues from resource-limited countries Includes case studies from different countries and focusses on special methodologies like active pharmacovigilance A special chapter on unique methodological challenges with the conduct of vaccine safety studies Guides the reader on training and funding opportunities in pharmacovigilance

Autorentext

Dr. Ahmad is a drug safety consultant who served the U.S. FDA for 15 years. He received his medical degree from Dow Medical College, Karachi; public health degree from Johns Hopkins, Baltimore, and did clinical pharmacology fellowship at Georgetown University, Washington, DC. Dr. Ahmad has a passion for teaching pharmacovigilance. He has conducted training in Eswatini, Cambodia, Kuwait, Laos, Oman, the Philippines, Pakistan, Palestine, Saudi Arabia, and the UAE.

He has contributed chapters in pharmacovigilance and the FDA approval process in seven textbooks including the past editions of Brian Strom's textbook on 'Pharmacoepidemiology' and Ron Mann's textbook on 'Pharmacovigilance'.